HomeSolutionsAboutTechnologyContact

Our technology

Bringing Artificial Intelligence (AI) to preventive care in general practice

What is Mosaic AI

Best-in-class natural language processing

Our best-in-class natural language processing can read and understand clinical notes, referral letters, and structured data, including observations (blood pressure, weight), pathology results or prescriptions.

The timeline

Market-ready Technology

Our core technology has been successfully applied in clinical care in rare disease specialist programs in Australia and Japan and in the primary care setting since 2015.

bullet point
2015
Garvan Institute of Medical Research

The roots of the technology and skillset underpinning Pryzm Health start at the Garvan Institute of Medical Research.

bullet point
2017
Australia’s largest commercial clinical genomics service

Genome.One

Mosaic AI was used in Genome.One, the world’s first clinically accredited lab to perform diagnosis of Rare Disorders using Whole Genome Sequencing.

bullet point
2017
Rare disease specialist programs

In Australia and Japan

It has been successfully applied in Australia (Western Australia Department of Health) and Japan (Japan Medical and Research Development Agency) - including in the first clinically accredited lab in Australia to perform rare disease diagnosis using whole genome sequencing.

bullet point
2018
Pryzm Health

Pryzm Health was founded in 2018 with a vision to bring beautiful patient-centric products powered by artificial intelligence and natural language processing to general practice in Australia

bullet point
2018
US largest rural not for profit health system

Sanford

Mosaic AI collected and analysed patient generated data and created precision patient profiles focused on generating actionable testing to inform precision drug preferences.

bullet point
2019
Primary Care

In the primary care setting, we are currently piloting the technology with a focus on two specific diseases, guided by commercial projects funded by two major (top 20) pharmaceutical companies

Why Choose Mosaic AI

bullet point
Over 4000 RD patients since 2015

Mosaic AI is currently used in clinical care in rare disease specialist programs in Australia and Japan and has aided clinical decision-making process for thousands of patients.

bullet point
Predictive Disease Diagnosis

Our intelligence core and disease ranking algorithm enables us to distinguish thousands of diseases, finding undiagnosed or under-treated patients sooner and faster.

bullet point
Next-level NLP

Our best-in-class natural language processing can read and understand clinical notes, referral letters, and structured data, including observations (blood pressure, weight), pathology results or prescriptions.

Interested in using Mosaic AI
for your practice?

Learn about Mosaic Assistant